TERIPARATID Mepha sol inj 250 mcg/ml 2.4 ml
7680661020017
CH-66102
H05AA02
07.99.0.
Reimbursement limitations:
FORSTEO 2
Pour un traitement en deuxième ligne de femmes post-ménopausées ou d'hommes qui développent de nouvelles …
1 / 3
google
Details
- Product number
- 6610201
- CPT
- -
- Packaging group
- 1
- Unit
- Injektor(en), vorgefüllt/Pen
- Composition
- teriparatidum 250 µg ut teriparatidi acetas, acidum aceticum glaciale, natrii acetas trihydricus, mannitolum, metacresolum, acidum hydrochloridum aut natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 0.09 mg.
Articles (1)
Teriparatid-Mepha, Injektionslösung im Fertigpen
Injektionslösung im Fertigpen
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
250.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Konservierungsstoff (Conservateur) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.09 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 225.60
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/07/2020
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 66102
- Drug name
- Teriparatid-Mepha, Injektionslösung im Fertigpen
- Galenic form
- INLFP
- ATC Code
- H05AA02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 17/11/2017
- Authorization expiration date
- 31/12/9999
- IT number
- 07.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TERIPARATID Mepha sol inj 250 mcg/ml 2.4 ml
- Description (DE)
- TERIPARATID Mepha Inj Lös 250 mcg/ml 2.4 ml
- Market launch
- 17/11/2017
- Narcotic (BTM)
- No